136 related articles for article (PubMed ID: 31127991)
1. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
Vitoratou DI; Tolia M; Liakos P; Tsoukalas N; Giaginis C; Nikolaou M; Nikolaou G; Rigas G; Psarianos K; Lioupis A; Kyrgias G
J BUON; 2019; 24(2):456-463. PubMed ID: 31127991
[TBL] [Abstract][Full Text] [Related]
2. Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Krawczyk MA; Styczewska M; Sokolewicz EM; Kunc M; Gabrych A; Fatyga A; Izycka-Swieszewska E; Kazanowska B; Adamkiewicz-Drozynska E; Bien E
Biomarkers; 2019 Sep; 24(6):538-548. PubMed ID: 30995126
[No Abstract] [Full Text] [Related]
3. Carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors.
Korkeila EA; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2011 Dec; 31(12):4529-35. PubMed ID: 22199327
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-related proteins in patients with rectal cancer undergoing neoadjuvant combined modality therapy.
Lee-Kong SA; Ruby JA; Chessin DB; Pucciarelli S; Shia J; Riedel ER; Nitti D; Guillem JG
Dis Colon Rectum; 2012 Sep; 55(9):990-5. PubMed ID: 22874607
[TBL] [Abstract][Full Text] [Related]
5. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
7. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
[TBL] [Abstract][Full Text] [Related]
8. Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancer.
Korkeila E; Sundström J; Pyrhönen S; Syrjänen K
Anticancer Res; 2012 Aug; 32(8):3299-303. PubMed ID: 22843905
[TBL] [Abstract][Full Text] [Related]
9. [Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy].
Cai C; Wang J; Zhong Z; Dai Z; Wang Q; Dong W; Shi H; Liu Q; DU J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 46(1):36-43. PubMed ID: 28436629
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer.
Havelund BM; Sørensen FB; Pløen J; Lindebjerg J; Spindler KL; Jakobsen A
APMIS; 2013 Feb; 121(2):127-38. PubMed ID: 23030583
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic tumor microenvironment in advanced retinoblastoma.
Sudhakar J; Venkatesan N; Lakshmanan S; Khetan V; Krishnakumar S; Biswas J
Pediatr Blood Cancer; 2013 Oct; 60(10):1598-601. PubMed ID: 23804414
[TBL] [Abstract][Full Text] [Related]
14. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiotherapy downregulates the nuclear expression of hypoxia-inducible factor-1alpha in rectal cancer.
Korkeila E; Jaakkola PM; Syrjänen K; Sundström J; Pyrhönen S
Scand J Gastroenterol; 2010 Mar; 45(3):340-8. PubMed ID: 20001759
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
18. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
19. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy.
Mayer A; Vaupel P; Oberholzer K; Ebert M; Dimitrow M; Kreft A; Mueller-Klieser W; Schmidberger H
Adv Exp Med Biol; 2016; 876():195-200. PubMed ID: 26782212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
